top of page

Pancreatic Cysts: Controversies, Advances, Diagnoses, and Therapies

  • Writer: Tony Vines
    Tony Vines
  • Apr 23, 2024
  • 1 min read

Logo for the National Institutes of Health

Date:

2017 Jul

PMID:

Category:

2

Authors:

Jodie A Barkin 1, Jamie S Barkin

Abstract:

Pancreatic cysts are commonly found on cross-sectional imaging. The question arises in determining which lesions are premalignant or malignant and may require further testing, intervention, or follow-up. In pancreatic cysts without obvious malignancy on imaging, we approach them using the Four "S" Criteria. These are (1) symptoms that may be originating from the pancreatic cyst; (2) size of the cyst 2 cm or larger and/or main pancreatic duct greater than 5 mm; (3) survival of the patient, based on comorbidity index to determine surgical fitness; and then endoscopic ultrasound with fine needle aspiration (FNA) recommended to determine (4) solid component presence in the cyst, namely, nodule or thick walls, as well as to perform FNA to obtain cyst content. Current cyst fluid analysis options include use of cytology to determine presence of malignancy and carcinoembryonic antigen and fluid genetics to identify potentially premalignant lesions. The aims of this article are to explore current management guidelines for pancreatic cysts, present a comprehensive approach to pancreatic cysts, and explain the advantages and disadvantages of each option for evaluation of pancreatic cysts including endoscopic ultrasound with FNA with cyst fluid analysis using an evidence-based approach.


 

Acknowledgements:

The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute, the National Institute of Health, or the National Institute of Diabetes and Digestive and Kidney Diseases.


The Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) Research Consortia is supported and funded by grants from the National Cancer Institute and the National Institute of Diabetes and Digestive and Kidney Diseases under the following award numbers:

Project Number:

Awardee Organization

U01DK108326

Baylor College of Medicine

U01DK108314

Cedars-Sinai Medical Center

U01DK108332

 Indiana University

U01DK108323

Kaiser Foundation Research Institute

U01DK108288

Mayo Clinic

U01DK108327

Ohio State University

U01DK108300

Stanford University

U01DK108320

University of Florida

U01DK108306

University of Pittsburgh

U01DK108328

University of Texas MD Anderson Cancer Center


Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page